Several options open for Cordlife after failed takeover of StemLife


One of the cryo containers that store umbilical cord blood and bone marrow samples at the private cord blood bank StemLife Bhd in Kuala Lumpur. The samples are kept in the stacked metal boxes to the left of the cylinder.

PETALING JAYA: It will be interesting to see the next step Singapore-listed Cordlife Group Ltd will take after the failed takeover of StemLife Bhd.

At this point in time, Cordlife has updated the market that it had received valid acceptances that gave it an 89.88% equity interest in StemLife on Tuesday.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Cordlife , Stemlife , privatisation

   

Next In Business News

FBM KLCI hits fresh two-year high as rally continues
Capital A chief Fernandes defers retirement, renews contract for 5 years
Australia Q1 inflation slowdown disappoints, rate cut bets gone
Ringgit rebounds on softer US$ after PMI data
Positive earnings outlook for Axis REIT
FBM KLCI remains in bullish mode on US corporate results beat
Trading ideas: MAHB, Capital A, Chin Hin, Cypark, Gadang, Comfort Gloves, HHRG, Haily
Inta Bina bags RM170mil job
Vehicle sales dip 10% in March to 71,052 units
Vietnam apparel companies raise concerns over 2H production

Others Also Read